相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 1 and Pharmacodynamic Study of Decitabine in Combination With Carboplatin in Patients With Recurrent, Platinum-Resistant, Epithelial Ovarian Cancer
Fang Fang et al.
CANCER (2010)
Smad Signaling Is Required to Maintain Epigenetic Silencing during Breast Cancer Progression
Panagiotis Papageorgis et al.
CANCER RESEARCH (2010)
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
Daniela E. Matei et al.
GYNECOLOGIC ONCOLOGY (2010)
Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou et al.
LABORATORY INVESTIGATION (2010)
An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules
Huaxia Qin et al.
BMC SYSTEMS BIOLOGY (2009)
Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
N. Steele et al.
BRITISH JOURNAL OF CANCER (2009)
An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
Her-Young Su et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
被撤回的出版物: DNA demethylation in hormone-induced transcriptional derepression (Retracted article. See vol. 486, pg. 280, 2012)
Mi-Sun Kim et al.
NATURE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Early events in the pathogenesis of epithelial ovarian cancer
Charles N. Landen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a smad3-dependent epithelial-to-mesenchymal transition
Thuy-Vy Do et al.
MOLECULAR CANCER RESEARCH (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
Nancy Dumont et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Aberrant transforming growth factor β1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer
Michael Chan et al.
NEOPLASIA (2008)
Concordant epigenetic silencing of transforming growth factor-β signaling pathway genes occurs early in breast carcinogenesis
Rebecca A. Hinshelwood et al.
CANCER RESEARCH (2007)
Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions
Shin-ichiro Takebayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors
Kim Appleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Inhibition of transforming growth factor β signaling reduces pancreatic adenocarcinoma growth and invasiveness
Nicholas J. Gaspar et al.
MOLECULAR PHARMACOLOGY (2007)
The role of chromatin during transcription
Bing Li et al.
CELL (2007)
Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation
Guillermo Barreto et al.
NATURE (2007)
Role of endocrine and growth factors on the ovarian surface epithelium
Alice S. T. Wong et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Joyce E. Ohm et al.
NATURE GENETICS (2007)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-β signaling in ovarian cancer
Jan S. Sunde et al.
CANCER RESEARCH (2006)
Histone modifications silence the GATA transcription factor genes in ovarian cancer
C. Caslini et al.
ONCOGENE (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
De novo CpG island methylation in human cancer cells
KW Jair et al.
CANCER RESEARCH (2006)
Impaired retinoic acid (RA) signal leads to RARβ2 epigenetic silencing and RA resistance
MQ Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies
F Lyko et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer
MWY Chan et al.
CLINICAL CANCER RESEARCH (2005)
Antimitogenic and chernosensitizing effects of the methylation inhibitor zebularine in ovarian cancer
C Balch et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine
JC Chuang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Promoter hypermethylation profile of ovarian epithelial neoplasms
PB Makarla et al.
CLINICAL CANCER RESEARCH (2005)
Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation
J Seoane et al.
CELL (2004)
Transforming growth factor-β1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells
Y Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The transforming growth factor-β superfamily of receptors
M de Caestecker
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type 1 receptor
WB Shi et al.
JOURNAL OF CELL BIOLOGY (2004)
Histones and histone modifications
CL Peterson et al.
CURRENT BIOLOGY (2004)
Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer
YW Leu et al.
CANCER RESEARCH (2004)
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex
H Peinado et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines -: Mechanisms for epithelial mesenchymal transitions
H Peinado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reactivating the expression of methylation silenced genes in human cancer
AR Karpf et al.
ONCOGENE (2002)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A cancer and leukemia group B study
AB Kornblith et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
Epigenetic reprogramming in mammalian development
W Reik et al.
SCIENCE (2001)
The adaptor molecule Disabled-2 links the transforming growth factor β receptors to the Smad pathway
BA Hocevar et al.
EMBO JOURNAL (2001)
Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-β superfamily -: Specialized binding regions for transforming growth factor-β and inhibin A
J Esparza-López et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation
T Ebisawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-β
GC Rodriguez et al.
GYNECOLOGIC ONCOLOGY (2001)
Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation
P Kavsak et al.
MOLECULAR CELL (2000)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
JF Costello et al.
NATURE GENETICS (2000)
分享论文
